Fuji Pharma Co., Ltd. (FUP.F)

9.40 +0.35 (+3.87%) At close: 08:10AM CEST

Fuji Pharma Co., Ltd.

Seitoh Kaikan
6th Floor 5-7 Sanban-cho Chiyoda-ku
Tokyo 102-0075
Japan
81 3 3556 3344
https://www.fujipharma.jp

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1,621

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Takayuki Iwai	President & CEO	N/A	N/A	1964
Mr. Toyoyuki Kamide	VP, Executive Officer & Director	N/A	N/A	1965
Mr. Seiichi Inoue	Managing Executive Officer & GM of Corporate Division	N/A	N/A	1958
Takeshi Sato	Managing Executive Officer	N/A	N/A	N/A
Atsushi Mitsuhashi	Managing Executive Officer & SCM Manager	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.

Corporate governance

Fuji Pharma Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.